Reopro Related Clinical Trials
A Study of Abciximab and Reteplase When Administered Prior to Catherization After a Myocardial Infarction (Finesse) [Completed]
ReoPro and Retavase to Treat Acute Stroke [Active, not recruiting]
ReoPro and Retavase to Restore Brain Blood Flow After Stroke [Active, not recruiting]
FATA: Randomized Study on Facilitated Angioplasty With Tirofiban or Abciximab [Completed]
A Study Comparing the Efficacy and Safety of Intracoronary Stenting With or Without Abciximab, an Anti-Platelet Therapy, and Conventional Coronary Angioplasty With Abciximab [Completed]
A Study of Effectiveness and Safety of Abciximab in Patients With Acute Ischemic Stroke (AbESTT-II) [Terminated]
Value of Abciximab in Patients With AMI Undergoing Primary PCI After Clopidogrel Pretreatment (BRAVE 3) [Completed]
Stroke Prevention With Abciximab in Carotid Endarterectomy [Terminated]
Multicentre 2x2 Factorial Randomised Study Comparing Tirofiban Versus Abciximab and SES Versus BMS in AMI [Active, not recruiting]
A Study Evaluating the Efficacy and Safety of Abciximab, an Anti-Platelet Therapy, in Patients Undergoing High-Risk Coronary Angioplasty [Completed]
Abciximab in Wake-up Stroke [Terminated]
Rio Trial - ReoPro and Peripheral Arterial Intervention to Improve Clinical Outcome in Patients With Peripheral Arterial Disease [Active, not recruiting]
Abciximab, Clopidogrel and Percutaneous Coronary Intervention in Acute Coronary Syndrome (ISAR-REACT-2) [Completed]
Abciximab i.v. Versus i.c. in Primary PCI Patients With STEMI [Active, not recruiting]
Myocardial Infarction With ST-Elevation [Recruiting]
Abciximab i.v. Versus i.c. in ST-Elevation Myocardial Infarction [Recruiting]
Periinterventional Abciximab + Heparin vs. Bivalirudin in Acute Coronary Syndrome (ISAR-REACT-4) [Recruiting]
EArly Discharge After Transradial Stenting of CoronarY Arteries: The EASY Study [Completed]
Intravenous Versus Intracoronary Use of Abciximab [Recruiting]
Efficacy Of Eptifibatide Compared To Abciximab In Primary Percutaneous Coronary Intervention (PCI) For Acute ST Elevation Myocardial Infarction (STEMI) [Completed]
Efficacy Study on Early Vs. Late Abciximab Administration During Primary Coronary Angioplasty [Recruiting]
Abciximab for Prevention of Stroke Recurrence Before Endarterectomy in Symptomatic Carotid Stenosis [Terminated]
A Study Comparing the Efficacy and Safety of Abciximab, an Anti-Platelet Therapy, in Combination With Two Different Heparin Regimens in Patients Undergoing Percutaneous Coronary Intervention. [Completed]
Abciximab in Patients Undergoing Percutaneous Coronary Intervention for Cardiogenic Shock [Recruiting]
Below Study - Balloonangioplasty or Stents With ReoPro for Prevention of Subacute Reocclusion in Arteries Below the Knee [Active, not recruiting]
A Randomized Trial of Early Discharge After Trans-Radial Stenting of Coronary Arteries in Acute MI and Rescue-PCI [Recruiting]
European Registry on STEMI Patients Transferred for PCI With Upstream Use of Abciximab - EuroTransfer Registry [Completed]
A Study Evaluating the Efficacy and Safety of Abciximab, an Anti-Platelet Therapy, in Patients With Unstable Angina Not Responding to Standard Medical Therapy Who Are Eligible for Coronary Angioplasty [Completed]
Half-Dose Intracoronary Abciximab Bolus Improves the Mortality Outcome Compared to Standard Intravenous Regimen [Terminated]
CARESS in Acute Myocardial Infarction [Completed]
A Randomized Trial of Early Discharge After Trans-Radial Stenting of Coronary Arteries in Acute MI [Recruiting]
Anti Ischemic Effects of Abciximab in Angioplasty and Stenting Patients [Recruiting]
Prospective Randomized Study Comparing Renal Artery Stenting (RESIST)With/Without Distal Protection [Active, not recruiting]
Study of ARC1779 in Patients With Acute Myocardial Infarction Undergoing PCI [Not yet recruiting]
Sirolimus Eluting Stenting in Acute Myocardial Infarction [Active, not recruiting]
Un-Fractionated Heparin vs. Bivalirudin During PCI (ISAR-REACT-3) [Active, not recruiting]
Primary Angioplasty for Acute Myocardial Infarction in Patients With Symptom Duration Above 12 Hours [Completed]
Angioplasty to Blunt the Rise of Troponin in Acute Coronary Syndrome (ACS) [Recruiting]
|
